Maynard Um
-
-
-
-
-
-
-
CorMedix (CRMD) Reiterated at Market Outperform by Citizens on Positive REZZAYO Results
-
-
-
-
-
-
-
CorMedix (CRMD) PT Lowered to $13 at H.C. Wainwright
-
-
-
-
-
-
-
D. Boral Capital Upgrades CorMedix (CRMD) to Buy
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on CorMedix (CRMD)
-
-
-
-
-
-
-
CorMedix (CRMD) Prices $85M Offering
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
CorMedix (CRMD) PT Raised to $12 as RBC Capital Sees a 'Supportive Setup for DefenCath into '25'
-
470,297 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


